Structure

Physi-Chem Properties

Molecular Weight:  474.23
Volume:  478.529
LogP:  3.092
LogD:  2.302
LogS:  -4.168
# Rotatable Bonds:  6
TPSA:  112.27
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.524
Synthetic Accessibility Score:  5.012
Fsp3:  0.654
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.961
MDCK Permeability:  2.8191430828883313e-05
Pgp-inhibitor:  0.996
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.088
20% Bioavailability (F20%):  0.027
30% Bioavailability (F30%):  0.887

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.412
Plasma Protein Binding (PPB):  75.75489044189453%
Volume Distribution (VD):  2.536
Pgp-substrate:  28.64593505859375%

ADMET: Metabolism

CYP1A2-inhibitor:  0.113
CYP1A2-substrate:  0.034
CYP2C19-inhibitor:  0.032
CYP2C19-substrate:  0.094
CYP2C9-inhibitor:  0.201
CYP2C9-substrate:  0.05
CYP2D6-inhibitor:  0.631
CYP2D6-substrate:  0.132
CYP3A4-inhibitor:  0.639
CYP3A4-substrate:  0.32

ADMET: Excretion

Clearance (CL):  3.015
Half-life (T1/2):  0.354

ADMET: Toxicity

hERG Blockers:  0.84
Human Hepatotoxicity (H-HT):  0.851
Drug-inuced Liver Injury (DILI):  0.898
AMES Toxicity:  0.082
Rat Oral Acute Toxicity:  0.795
Maximum Recommended Daily Dose:  0.191
Skin Sensitization:  0.44
Carcinogencity:  0.318
Eye Corrosion:  0.012
Eye Irritation:  0.012
Respiratory Toxicity:  0.973

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC88007

Natural Product ID:  NPC88007
Common Name*:   Caesalamin C
IUPAC Name:   [(1S,4aR,5S,6R,6aR,11aS,11bS)-5,6-diacetyloxy-4a-hydroxy-4,4,11b-trimethyl-7-methylidene-1,2,3,5,6,6a,11,11a-octahydronaphtho[2,1-f][1]benzofuran-1-yl] acetate
Synonyms:   caesalamin C
Standard InCHIKey:  LNEQDVOGNPILGB-WOWNGYFCSA-N
Standard InCHI:  InChI=1S/C26H34O8/c1-13-17-9-11-31-19(17)12-18-21(13)22(33-15(3)28)23(34-16(4)29)26(30)24(5,6)10-8-20(25(18,26)7)32-14(2)27/h9,11,18,20-23,30H,1,8,10,12H2,2-7H3/t18-,20-,21-,22+,23-,25-,26+/m0/s1
SMILES:  CC(=O)O[C@@H]1[C@H]2C(=C)c3ccoc3C[C@@H]2[C@@]2([C@]([C@H]1OC(=O)C)(O)C(C)(C)CC[C@@H]2OC(=O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL463460
PubChem CID:   10457606
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[11678648]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. Indonesia n.a. PMID[15921414]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. seed kernel n.a. PMID[15921414]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota Seeds n.a. n.a. PMID[23806110]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota Seeds n.a. n.a. PMID[24303808]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26402 Caesalpinia crista Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT336 Organism Human parainfluenza virus 3 Human parainfluenza virus 3 IC50 = 8.2 ug.mL-1 PMID[457110]
NPT27 Others Unspecified LC50 = 196.3 ug.mL-1 PMID[457110]
NPT27 Others Unspecified TI = 23.9 n.a. PMID[457110]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC88007 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9866 High Similarity NPC195954
0.9866 High Similarity NPC194499
0.9801 High Similarity NPC68848
0.9671 High Similarity NPC188649
0.9608 High Similarity NPC285567
0.9608 High Similarity NPC88841
0.9608 High Similarity NPC288602
0.9605 High Similarity NPC8389
0.9597 High Similarity NPC121615
0.9597 High Similarity NPC294511
0.9595 High Similarity NPC228842
0.9595 High Similarity NPC212257
0.9542 High Similarity NPC79571
0.9536 High Similarity NPC41880
0.9484 High Similarity NPC121995
0.9481 High Similarity NPC283209
0.9474 High Similarity NPC7059
0.9416 High Similarity NPC18986
0.9392 High Similarity NPC71821
0.9363 High Similarity NPC296558
0.9359 High Similarity NPC277618
0.9351 High Similarity NPC287559
0.9299 High Similarity NPC270312
0.9281 High Similarity NPC104736
0.9267 High Similarity NPC69647
0.9267 High Similarity NPC125182
0.9262 High Similarity NPC255414
0.9221 High Similarity NPC304692
0.9172 High Similarity NPC56358
0.9161 High Similarity NPC474611
0.9119 High Similarity NPC291742
0.9108 High Similarity NPC476035
0.9108 High Similarity NPC14499
0.9108 High Similarity NPC475039
0.9062 High Similarity NPC118086
0.9054 High Similarity NPC263337
0.9026 High Similarity NPC302054
0.9026 High Similarity NPC253201
0.9013 High Similarity NPC211625
0.9006 High Similarity NPC294512
0.9006 High Similarity NPC475641
0.9006 High Similarity NPC475237
0.9 High Similarity NPC5676
0.9 High Similarity NPC255787
0.8994 High Similarity NPC308156
0.8987 High Similarity NPC472773
0.8974 High Similarity NPC81405
0.8961 High Similarity NPC472672
0.8961 High Similarity NPC268905
0.8938 High Similarity NPC310572
0.8931 High Similarity NPC126984
0.8931 High Similarity NPC61967
0.8931 High Similarity NPC27541
0.8931 High Similarity NPC62692
0.8926 High Similarity NPC121158
0.8924 High Similarity NPC470792
0.8924 High Similarity NPC82851
0.8924 High Similarity NPC200782
0.8924 High Similarity NPC472771
0.8917 High Similarity NPC140952
0.8903 High Similarity NPC34421
0.8903 High Similarity NPC237259
0.8903 High Similarity NPC98206
0.8882 High Similarity NPC160651
0.8875 High Similarity NPC475779
0.8875 High Similarity NPC86800
0.8868 High Similarity NPC469338
0.8868 High Similarity NPC292389
0.8854 High Similarity NPC472776
0.8854 High Similarity NPC299038
0.8854 High Similarity NPC472778
0.8854 High Similarity NPC472777
0.8851 High Similarity NPC202260
0.8848 High Similarity NPC11062
0.8846 High Similarity NPC264943
0.8841 High Similarity NPC56953
0.8841 High Similarity NPC176413
0.8839 High Similarity NPC476201
0.8827 High Similarity NPC88593
0.882 High Similarity NPC173516
0.882 High Similarity NPC41689
0.882 High Similarity NPC472775
0.882 High Similarity NPC472774
0.8812 High Similarity NPC470182
0.8812 High Similarity NPC470940
0.8812 High Similarity NPC276735
0.8812 High Similarity NPC469849
0.8812 High Similarity NPC276551
0.8805 High Similarity NPC329938
0.8797 High Similarity NPC472671
0.8797 High Similarity NPC84349
0.8797 High Similarity NPC475967
0.8797 High Similarity NPC123153
0.8782 High Similarity NPC114880
0.8782 High Similarity NPC282445
0.8765 High Similarity NPC271235
0.8765 High Similarity NPC471397
0.8758 High Similarity NPC470875
0.8758 High Similarity NPC216755
0.8758 High Similarity NPC472141
0.875 High Similarity NPC302369
0.875 High Similarity NPC477405
0.875 High Similarity NPC39986
0.875 High Similarity NPC134254
0.8742 High Similarity NPC472653
0.8734 High Similarity NPC249021
0.8734 High Similarity NPC472772
0.8734 High Similarity NPC475066
0.8734 High Similarity NPC214495
0.8734 High Similarity NPC470119
0.8734 High Similarity NPC470118
0.8734 High Similarity NPC167142
0.8726 High Similarity NPC141538
0.8726 High Similarity NPC155939
0.8726 High Similarity NPC476262
0.8726 High Similarity NPC92979
0.8726 High Similarity NPC296807
0.8718 High Similarity NPC246164
0.8718 High Similarity NPC469503
0.8718 High Similarity NPC33938
0.8716 High Similarity NPC307401
0.8712 High Similarity NPC470995
0.871 High Similarity NPC470997
0.8704 High Similarity NPC472282
0.8704 High Similarity NPC473766
0.8704 High Similarity NPC473753
0.8701 High Similarity NPC19747
0.8693 High Similarity NPC62799
0.8688 High Similarity NPC471003
0.8688 High Similarity NPC69028
0.8688 High Similarity NPC263432
0.8684 High Similarity NPC251865
0.8679 High Similarity NPC475226
0.8679 High Similarity NPC307383
0.8675 High Similarity NPC472665
0.8667 High Similarity NPC67003
0.8654 High Similarity NPC18135
0.8645 High Similarity NPC234494
0.8642 High Similarity NPC93172
0.8642 High Similarity NPC97574
0.8636 High Similarity NPC286038
0.8636 High Similarity NPC471174
0.8634 High Similarity NPC476197
0.8634 High Similarity NPC472139
0.8625 High Similarity NPC472299
0.8625 High Similarity NPC470789
0.8625 High Similarity NPC335761
0.8625 High Similarity NPC477402
0.8625 High Similarity NPC25255
0.8618 High Similarity NPC243577
0.8616 High Similarity NPC45101
0.8616 High Similarity NPC469847
0.8616 High Similarity NPC197137
0.8616 High Similarity NPC261597
0.8616 High Similarity NPC1408
0.8616 High Similarity NPC36655
0.8616 High Similarity NPC246841
0.8608 High Similarity NPC214541
0.8608 High Similarity NPC469336
0.8608 High Similarity NPC75310
0.8608 High Similarity NPC44675
0.86 High Similarity NPC171207
0.86 High Similarity NPC97667
0.8599 High Similarity NPC29695
0.8599 High Similarity NPC182427
0.8599 High Similarity NPC322546
0.8599 High Similarity NPC308205
0.8598 High Similarity NPC302392
0.859 High Similarity NPC476122
0.8589 High Similarity NPC472651
0.8581 High Similarity NPC66991
0.8581 High Similarity NPC471007
0.858 High Similarity NPC476857
0.858 High Similarity NPC476856
0.858 High Similarity NPC271657
0.858 High Similarity NPC476858
0.8571 High Similarity NPC5079
0.8571 High Similarity NPC207978
0.8571 High Similarity NPC193798
0.8571 High Similarity NPC18347
0.8571 High Similarity NPC470939
0.8571 High Similarity NPC149896
0.8562 High Similarity NPC477403
0.8553 High Similarity NPC469485
0.8553 High Similarity NPC107646
0.8544 High Similarity NPC178932
0.8544 High Similarity NPC30222
0.8543 High Similarity NPC291599
0.8543 High Similarity NPC118080
0.8543 High Similarity NPC87448
0.8543 High Similarity NPC16912
0.8543 High Similarity NPC97947
0.8543 High Similarity NPC148374
0.8543 High Similarity NPC27377
0.8543 High Similarity NPC41481
0.8543 High Similarity NPC472576
0.8537 High Similarity NPC472652
0.8535 High Similarity NPC119252
0.8528 High Similarity NPC307781
0.8528 High Similarity NPC472670

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC88007 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8802 High Similarity NPD8434 Phase 2
0.8261 Intermediate Similarity NPD5760 Phase 2
0.8261 Intermediate Similarity NPD5761 Phase 2
0.8194 Intermediate Similarity NPD4628 Phase 3
0.8176 Intermediate Similarity NPD6765 Approved
0.8176 Intermediate Similarity NPD6764 Approved
0.7989 Intermediate Similarity NPD6784 Approved
0.7989 Intermediate Similarity NPD6785 Approved
0.7952 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7819 Suspended
0.7927 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD7075 Discontinued
0.7886 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD6559 Discontinued
0.7857 Intermediate Similarity NPD8127 Discontinued
0.7853 Intermediate Similarity NPD6599 Discontinued
0.7831 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD5844 Phase 1
0.7785 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD6273 Approved
0.7683 Intermediate Similarity NPD7458 Discontinued
0.7674 Intermediate Similarity NPD7473 Discontinued
0.7665 Intermediate Similarity NPD3817 Phase 2
0.7654 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD6801 Discontinued
0.7625 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7617 Intermediate Similarity NPD8404 Phase 2
0.7605 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD6799 Approved
0.759 Intermediate Similarity NPD7411 Suspended
0.7588 Intermediate Similarity NPD5494 Approved
0.7576 Intermediate Similarity NPD3226 Approved
0.7574 Intermediate Similarity NPD3749 Approved
0.7561 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD920 Approved
0.756 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD37 Approved
0.7545 Intermediate Similarity NPD1934 Approved
0.7544 Intermediate Similarity NPD7199 Phase 2
0.7531 Intermediate Similarity NPD7236 Approved
0.753 Intermediate Similarity NPD4380 Phase 2
0.7529 Intermediate Similarity NPD6234 Discontinued
0.7529 Intermediate Similarity NPD919 Approved
0.7529 Intermediate Similarity NPD3818 Discontinued
0.7515 Intermediate Similarity NPD4967 Phase 2
0.7515 Intermediate Similarity NPD4966 Approved
0.7515 Intermediate Similarity NPD4965 Approved
0.75 Intermediate Similarity NPD6232 Discontinued
0.7484 Intermediate Similarity NPD6100 Approved
0.7484 Intermediate Similarity NPD6099 Approved
0.7473 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD8312 Approved
0.7472 Intermediate Similarity NPD8313 Approved
0.7471 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD6355 Discontinued
0.7439 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD6166 Phase 2
0.7414 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD3882 Suspended
0.741 Intermediate Similarity NPD7239 Suspended
0.7407 Intermediate Similarity NPD3750 Approved
0.7401 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD2796 Approved
0.7372 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7354 Intermediate Similarity NPD7497 Discontinued
0.7353 Intermediate Similarity NPD5402 Approved
0.7349 Intermediate Similarity NPD5403 Approved
0.7345 Intermediate Similarity NPD7074 Phase 3
0.7341 Intermediate Similarity NPD6959 Discontinued
0.7333 Intermediate Similarity NPD5401 Approved
0.7333 Intermediate Similarity NPD2532 Approved
0.7333 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2534 Approved
0.7333 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2533 Approved
0.733 Intermediate Similarity NPD7228 Approved
0.733 Intermediate Similarity NPD7799 Discontinued
0.7329 Intermediate Similarity NPD2346 Discontinued
0.7325 Intermediate Similarity NPD8032 Phase 2
0.7314 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD2799 Discontinued
0.7312 Intermediate Similarity NPD3748 Approved
0.731 Intermediate Similarity NPD7768 Phase 2
0.7308 Intermediate Similarity NPD7095 Approved
0.7303 Intermediate Similarity NPD1608 Approved
0.7301 Intermediate Similarity NPD4110 Phase 3
0.7301 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD7003 Approved
0.7301 Intermediate Similarity NPD8166 Discontinued
0.7299 Intermediate Similarity NPD7229 Phase 3
0.7294 Intermediate Similarity NPD8455 Phase 2
0.7294 Intermediate Similarity NPD1465 Phase 2
0.7294 Intermediate Similarity NPD2801 Approved
0.7288 Intermediate Similarity NPD7054 Approved
0.7288 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD1549 Phase 2
0.7268 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD1551 Phase 2
0.7263 Intermediate Similarity NPD7685 Pre-registration
0.7261 Intermediate Similarity NPD3764 Approved
0.7261 Intermediate Similarity NPD6798 Discontinued
0.7256 Intermediate Similarity NPD6190 Approved
0.7253 Intermediate Similarity NPD8150 Discontinued
0.725 Intermediate Similarity NPD7097 Phase 1
0.7247 Intermediate Similarity NPD7472 Approved
0.7241 Intermediate Similarity NPD1247 Approved
0.7239 Intermediate Similarity NPD1243 Approved
0.7238 Intermediate Similarity NPD8407 Phase 2
0.7222 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD5762 Approved
0.7222 Intermediate Similarity NPD5763 Approved
0.7222 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD1471 Phase 3
0.7215 Intermediate Similarity NPD6233 Phase 2
0.7205 Intermediate Similarity NPD7033 Discontinued
0.7197 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD4140 Approved
0.7169 Intermediate Similarity NPD1511 Approved
0.7167 Intermediate Similarity NPD7251 Discontinued
0.7167 Intermediate Similarity NPD8368 Discontinued
0.7167 Intermediate Similarity NPD7240 Approved
0.7159 Intermediate Similarity NPD3926 Phase 2
0.7152 Intermediate Similarity NPD3268 Approved
0.7152 Intermediate Similarity NPD2313 Discontinued
0.7135 Intermediate Similarity NPD3751 Discontinued
0.7135 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2800 Approved
0.7134 Intermediate Similarity NPD6832 Phase 2
0.7127 Intermediate Similarity NPD7808 Phase 3
0.7127 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD2344 Approved
0.7117 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6004 Phase 3
0.7117 Intermediate Similarity NPD6002 Phase 3
0.7117 Intermediate Similarity NPD6005 Phase 3
0.7111 Intermediate Similarity NPD6797 Phase 2
0.7105 Intermediate Similarity NPD17 Approved
0.7102 Intermediate Similarity NPD3787 Discontinued
0.7099 Intermediate Similarity NPD4308 Phase 3
0.7099 Intermediate Similarity NPD1510 Phase 2
0.7083 Intermediate Similarity NPD1512 Approved
0.7083 Intermediate Similarity NPD7435 Discontinued
0.7078 Intermediate Similarity NPD3972 Approved
0.7055 Intermediate Similarity NPD2438 Suspended
0.7055 Intermediate Similarity NPD2935 Discontinued
0.7052 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD2797 Approved
0.7048 Intermediate Similarity NPD3887 Approved
0.7048 Intermediate Similarity NPD2354 Approved
0.7039 Intermediate Similarity NPD7177 Discontinued
0.7019 Intermediate Similarity NPD230 Phase 1
0.7019 Intermediate Similarity NPD5735 Approved
0.7018 Intermediate Similarity NPD7028 Phase 2
0.7016 Intermediate Similarity NPD4107 Approved
0.7011 Intermediate Similarity NPD7058 Phase 2
0.7011 Intermediate Similarity NPD7057 Phase 3
0.7 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.6993 Remote Similarity NPD1778 Approved
0.6989 Remote Similarity NPD8361 Approved
0.6989 Remote Similarity NPD8360 Approved
0.6989 Remote Similarity NPD8435 Approved
0.6975 Remote Similarity NPD6653 Approved
0.6975 Remote Similarity NPD1607 Approved
0.6973 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6957 Remote Similarity NPD4307 Phase 2
0.6957 Remote Similarity NPD1240 Approved
0.6957 Remote Similarity NPD4060 Phase 1
0.6946 Remote Similarity NPD2309 Approved
0.6943 Remote Similarity NPD3266 Approved
0.6943 Remote Similarity NPD3267 Approved
0.6943 Remote Similarity NPD3057 Approved
0.6937 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6927 Remote Similarity NPD6779 Approved
0.6927 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6927 Remote Similarity NPD6782 Approved
0.6927 Remote Similarity NPD6776 Approved
0.6927 Remote Similarity NPD6781 Approved
0.6927 Remote Similarity NPD6778 Approved
0.6927 Remote Similarity NPD6780 Approved
0.6927 Remote Similarity NPD6777 Approved
0.6914 Remote Similarity NPD447 Suspended
0.6899 Remote Similarity NPD2798 Approved
0.6899 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6894 Remote Similarity NPD6663 Approved
0.6891 Remote Similarity NPD4482 Phase 3
0.6882 Remote Similarity NPD5049 Phase 3
0.6879 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6385 Approved
0.6879 Remote Similarity NPD1283 Approved
0.6879 Remote Similarity NPD6677 Suspended
0.6879 Remote Similarity NPD6386 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data